The DOI matches its Crossref record; 26 of the 26 references it cites were found in a registry or an index.
Combined Oral Contraceptives in Women with Systemic Lupus Erythematosus
Open accessAbstract
BACKGROUND: Oral contraceptives are rarely prescribed for women with systemic lupus erythematosus, because of concern about potential negative side effects. In this double-blind, randomized, noninferiority trial, we prospectively evaluated the effect of oral contraceptives on lupus activity in premenopausal women with systemic lupus erythematosus. METHODS: A total of 183 women with inactive (76 percent) or stable active (24 percent) systemic lupus erythematosus at 15 U.S. sites were randomly assigned to receive either oral contraceptives (triphasic ethinyl estradiol at a dose of 35 microg plus norethindrone at a dose of 0.5 to 1 mg for 12 cycles of 28 days each; 91 women) or placebo (92 women) and were evaluated at months 1, 2, 3, 6, 9, and 12. Subjects were excluded if they had moderate or high levels of anticardiolipin antibodies, lupus anticoagulant, or a history of thrombosis. RESULTS: The primary end point, a severe lupus flare, occurred in 7 of 91 subjects receiving oral contraceptives (7.7 percent) as compared with 7 of 92 subjects receiving placebo (7.6 percent). The 12-month rates of severe flare were similar: 0.084 for the group receiving oral contraceptives and 0.087 for the placebo group (P=0.95; upper limit of the one-sided 95 percent confidence interval for this difference, 0.069, which is within the prespecified 9 percent margin for noninferiority). Rates of mild or moderate flares were 1.40 flares per person-year for subjects receiving oral contraceptives and 1.44 flares per person-year for subjects receiving placebo (relative risk, 0.98; P=0.86). In the group that was randomized to receive oral contraceptives, there was one deep venous thrombosis and one clotted graft; in the placebo group, there was one deep venous thrombosis, one ocular thrombosis, one superficial thrombophlebitis, and one death (after cessation of the trial). CONCLUSIONS: Our study indicates that oral contraceptives do not increase the risk of flare among women with systemic lupus erythematosus whose disease is stable.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The 1982 revised criteria for the classification of systemic lupus erythematosus
Tan, E. M., Cohen, A. S., Fries, J. F., Masi, A. T., Mcshane, D. J., Rothfield, N. F., Schaller, J. G., Talal, N., & Winchester, R. J. (1982) · Arthritis & Rheumatism · doi:10.1002/art.1780251101 · Cited by 14,519
Derivation of the sledai. A disease activity index for lupus patients
Bombardier, C., Gladman, D. D., Urowitz, M. B., Caron, D., Chang, C. H., Austin, A., Bell, A., Bloch, D. A., Corey, P. N., Decker, J. L., et al. (1992) · Arthritis & Rheumatism · doi:10.1002/art.1780350606 · Cited by 4,570
Self-citationIncreased Osteoclast Development After Estrogen Loss: Mediation by Interleukin-6
Jilka, R. L., Hangoc, G., Girasole, G., Passeri, G., Williams, D. C., Abrams, J. S., Boyce, B., Broxmeyer, H., & Manolagas, S. C. (1992) · Science · doi:10.1126/science.1621100 · Cited by 1,442
Recommendations for the prevention and treatment of glucocorticoid‐induced osteoporosis
American College of Rheumatology task force on Osteoporosis guidelines (1996) · Arthritis & Rheumatism · doi:10.1002/art.1780391104 · Cited by 848
Buyon, J. P., Petri, M. A., Kim, M. Y., Kalunian, K. C., Grossman, J., Hahn, B. H., Merrill, J. T., Sammaritano, L., Lockshin, M., Alarcón, G. S., et al. (2005) · Annals of Internal Medicine · doi:10.7326/0003-4819-142-12_part_1-200506210-00004 · Cited by 661
Self-citationHip Fracture and the Use of Estrogens in Postmenopausal Women
Kiel, D. P., Felson, D. T., Anderson, J. J., Wilson, P. W. F., & Moskowitz, M. A. (1987) · New England Journal of Medicine · doi:10.1056/nejm198711053171901 · Cited by 632
Hip Fracture and the Use of Estrogens in Postmenopausal Women: The Framingham Study
KIEL, D. P., FELSON, D. T., ANDERSON, J. J., WILSON, P. W. F., & MOSKOWITZ, M. A. (1988) · Obstetrical & Gynecological Survey · doi:10.1097/00006254-198807000-00018 · Cited by 625
Estrogen alters thresholds for B cell apoptosis and activation
Grimaldi, C. M., Cleary, J., Dagtas, A. S., Moussai, D., & Diamond, B. (2002) · Journal of Clinical Investigation · doi:10.1172/jci14873 · Cited by 461
Self-citationOral contraceptive discontinuation: A prospective evaluation of frequency and reasons
Rosenberg, M. J., & Waugh, M. S. (1998) · American Journal of Obstetrics and Gynecology · doi:10.1016/s0002-9378(98)70047-x · Cited by 435
GALLAGHER, J. C., RIGGS, B. L., & DELUCA, H. F. (1980) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-51-6-1359 · Cited by 428
Estrogen alters thresholds for B cell apoptosis and activation
Grimaldi, C. M., Cleary, J., Dagtas, A. S., Moussai, D., & Diamond, B. (2002) · Journal of Clinical Investigation · doi:10.1172/jci0214873 · Cited by 425
Self-citationOvarian steroid treatment blocks a postmenopausal increase in blood monocyte interleukin 1 release.
Pacifici, R., Rifas, L., McCracken, R., Vered, I., McMurtry, C., Avioli, L. V., & Peck, W. A. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.7.2398 · Cited by 375
Contraceptive Failure in the United States: A Critical Review of the Literature
Trussell, J., & Kost, K. (1987) · Studies in Family Planning · doi:10.2307/1966856 · Cited by 286
Classification and definition of major flares in SLE clinical trials
Petri, M., Buyon, J., & Kim, M. (1999) · Lupus · doi:10.1191/096120399680411281 · Cited by 282
Self-citationInfluence of oral contraceptive therapy on the activity of systemic lupus erythematosus
Jungers, P., Dougados, M., Pélissier, C., Kuttenn, F., Tron, F., Lesavre, P., & Bach, J.-F. (1982) · Arthritis & Rheumatism · doi:10.1002/art.1780250603 · Cited by 269
Sex hormone modulation of autoimmunity in NZB/NZW mice
Roubinian, J., Talal, N., Siiteri, P. K., & Sadakian, J. A. (1979) · Arthritis & Rheumatism · doi:10.1002/art.1780221102 · Cited by 233
(1996) · JAMA · doi:10.1001/jama.276.17.1389 · Cited by 196
Systemic Lupus Erythematosus in Pregnancy
FINE, L. G., BARNETT, E. V., DANOVITCH, G. M., NISSENSON, A. R., CONOLLY, M. E., LIEB, S. M., & BARRETT, C. T. (1981) · Annals of Internal Medicine · doi:10.7326/0003-4819-94-5-667 · Cited by 193
Musculoskeletal complications of systemic lupus erythematosus in the hopkins lupus cohort: An update
Petri, M. (1995) · Arthritis & Rheumatism · doi:10.1002/art.1790080305 · Cited by 187
Self-citationRamsey-Goldman, R., Dunn, J. E., Huang, C.-F., Dunlop, D., Rairie, J. E., Fitzgerald, S., & Manzi, S. (1999) · Arthritis & Rheumatism · doi:10.1002/1529-0131(199905)42:5<882::aid-anr6>3.0.co;2-c · Cited by 186
Cooper, G. S., Dooley, M. A., Treadwell, E. L., St.Clair, E. W., & Gilkeson, G. S. (2002) · Arthritis & Rheumatism · doi:10.1002/art.10365 · Cited by 182
Self-citationPast use of oral contraceptives and the risk of developing systemic lupus erythematosus
Sanchez‐Guerrero, J., Karlson, E. W., Liang, M. H., Hunter, D. J., Speizer, F. E., & Colditz, G. A. (1997) · Arthritis & Rheumatism · doi:10.1002/art.1780400505 · Cited by 177
Sex effects in systemic lupus erythematosus. a clue to pathogenesis
Masi, A. T., & Kaslow, R. A. (1978) · Arthritis & Rheumatism · doi:10.1002/art.1780210413 · Cited by 161
Oral contraceptives and systemic lupus erythematosus
Petri, M., & Robinson, C. (1997) · Arthritis & Rheumatism · doi:10.1002/art.1780400504 · Cited by 117
Self-citationJulkunen, H. A. (1991) · Scandinavian Journal of Rheumatology · doi:10.3109/03009749109096822 · Cited by 109
Estrogen metabolism in systemic lupus erythematosus. Patients and family members
Lahita, R. G., Bradlow, L., Fishman, J., & Kunkel, H. G. (1982) · Arthritis & Rheumatism · doi:10.1002/art.1780250726 · Cited by 102
Cited by
KDIGO 2021 Clinical Practice Guideline for the Management of Glomerular Diseases
Rovin, B. H., Adler, S. G., Barratt, J., Bridoux, F., Burdge, K. A., Chan, T. M., Cook, H. T., Fervenza, F. C., Gibson, K. L., Glassock, R. J., et al. (2021) · Kidney International · doi:10.1016/j.kint.2021.05.021 · Cited by 2,518
Navarra, S. V., Guzmán, R. M., Gallacher, A. E., Hall, S., Levy, R. A., Jimenez, R. E., Li, E. K.-M., Thomas, M., Kim, H.-Y., León, M. G., et al. (2011) · The Lancet · doi:10.1016/s0140-6736(10)61354-2 · Cited by 2,074
Self-citationThe complex role of estrogens in inflammation
Straub, R. H. (2007) · Endocrine Reviews · doi:10.1210/er.2007-0001 · Cited by 1,950
Furie, R., Petri, M., Zamani, O., Cervera, R., Wallace, D. J., Tegzová, D., Sanchez-Guerrero, J., Schwarting, A., Merrill, J. T., Chatham, W. W., et al. (2011) · Arthritis & Rheumatism · doi:10.1002/art.30613 · Cited by 1,683
Self-citationU.S. Medical Eligibility Criteria for Contraceptive Use, 2016
Curtis, K. M., Tepper, N. K., Jatlaoui, T. C., Berry-Bibee, E., Horton, L. G., Zapata, L. B., Simmons, K. B., Pagano, H. P., Jamieson, D. J., & Whiteman, M. K. (2016) · MMWR. Recommendations and Reports · doi:10.15585/mmwr.rr6503a1 · Cited by 1,456
Metadata
- Authors
- Petri, M., Kim, M. Y., Kalunian, K. C., Grossman, J., Hahn, B. H., Sammaritano, L. R., Lockshin, M., Merrill, J. T., Belmont, H. M., Askanase, A. D., McCune, W. J., Hearth-Holmes, M., Dooley, M. A., Von Feldt, J., Friedman, A., Tan, M., Davis, J., Cronin, M., Diamond, B., Mackay, M., Sigler, L., Fillius, M., Rupel, A., Licciardi, F., & Buyon, J. P.
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2005-12-15
- Volume
- 353
- Issue
- 24
- Pages
- 2550-2558
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2141455950
- Cited by
- 1,166
- References
- 26
- FWCI
- 15.02
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.